Mint-Imatinib 400 mg (Imatinib (Imatinib Mesylate) TABLET) 400 MG

Mint-Imatinib 400 mg tablets are a pharmaceutical product containing imatinib mesylate, used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

Strength

400 MG

Manufacturer / TM Owner

MINT PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mint-Imatinib 400 mg tablets are primarily used in the management of certain types of cancer. Imatinib mesylate, the active ingredient, is often utilized in targeted therapy to inhibit the growth of cancer cells. This medication is commonly prescribed for conditions where specific proteins are involved in the progression of the disease. Patients should consult their healthcare provider to understand what is imatinib used for in their specific case.

Side Effects

Common effects of Mint-Imatinib 400 mg tablets may include nausea, fatigue, and muscle cramps. Some individuals might experience swelling, rash, or changes in blood counts. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

Mint-Imatinib 400 mg tablets should be handled with care, stored in a cool, dry place, and kept out of reach of children. Patients with liver or kidney issues should discuss their condition with a healthcare provider before starting this medication. Regular medical check-ups are recommended to monitor the effects of the treatment.

Avoid Interactions

Mint-Imatinib 400 mg tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional to avoid potential interactions.

Frequently Asked Questions

Mint-Imatinib 400 mg tablets are used in the management of certain types of cancer, targeting specific proteins involved in the disease.

Store Mint-Imatinib 400 mg tablets in a cool, dry place, away from direct sunlight and out of reach of children.

Common side effects may include nausea, fatigue, muscle cramps, swelling, rash, and changes in blood counts.

Mint-Imatinib 400 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Patients with liver issues should discuss their condition with a healthcare provider before starting Mint-Imatinib 400 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.